Jasplakinolide: Interaction with radiation and hyperthermia in human prostate carcinoma and Lewis lung carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 6, 1998, Pages 491-496

  Takeuchi, Hideya ^a   Ara, Gulshan ^a   Sausville, Edward A ^b   Teicher, Beverly ^a,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Hyperthermia; Jasplakinolide; Prostate cancer; Radiation sensitization

Indexed keywords

ANTINEOPLASTIC AGENT; JASPAMIDE; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL CYCLE; CELL SURVIVAL; HUMAN; HUMAN CELL; HYPERTHERMIA; LEWIS CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CELL DIVISION; COMBINED MODALITY THERAPY; DEPSIPEPTIDES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MICE; PEPTIDES, CYCLIC; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031668959     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050850     Document Type: Article

References (22)

1. Allen TM, Sharma A, Dubin RE (1986) Potential new anticancer drugs from marine organisms collected at Enewetak atoll. Marine Sci 38: 4
2. Bubb MR, Senderowicz AMJ, Sausville EA (1994) Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J Biol Chem 269: 14869
3. Bubley G, Balk S (1996) Treatment of metastatic prostate cancer. Prostate Cancer 10: 713
4. Bubley G, Balk S (1996) Treatment of androgen-independent prostate cancer. Oncologist 1: 30
5. Crews P, Manes LV, Boehler M (1986) Jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis. Tetrahedron Lett 27: 2797
6. Duncan MD, JW Harmon, Duncan LK (1996) Actin disruption inhibits bombesin stimulation of focal adhesion kinase in prostate carcinoma. J Surg Res 63: 359
7. Fabian I, Shur I, Bleiberg I, et al (1995) Growth modulation and differentiation of acute myeloid leukemia cells by Jaspamide. Exp Hematol 23: 583
8. Kaver I, Ware JL, Koontz Jr WW (1989) The effect of hyperthermia on human prostatic carcinoma cell Lines: evaluation in vitro. J Urol 141: 1025
9. Mani S, Vogelzang N (1996) Is "Off-protocol" chemotherapy for androgen indepenent carcinoma of prostate warranted? Prostate Cancer 10: 749
10. Matthews JB, Smith JA, Hrnjez BJ (1997) Effects of F-actin stabilization or disassembly on epithelial Cl-secretion and NaK-2Cl contransport. Am J Physiol 272: C254
11. O'Neill FJ (1975) Selective destruction of cultured tumor cells with uncontrolled nuclear cytochalasin division by cytochalasin B and cytosine arabinoside. Cancer Res 35: 3111-3115
12. Ruggieri GD (1976) Drugs from the sea: marine organisms with novel chemical constituents are excellent sources of new drugs. Science 194: 491
13. Scheuer PJ (1990) Some marine ecological phenomena: chemical basis and biomedical potential. Science 248: 173
14. Senderowicz AMJ, Kaur G, Sainz E et al (1995) Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. J Natl Cancer Inst 87: 46
15. Shibamoto Y, Shelter C, Fuhrmann C, Budach V (1991) Tumor radiosensitivity prediction by the cytokinesis block micronucleus assay. Radiat Res 128: 293-300
16. Stingl J, Andersen RJ, Emerman T (1992) In vitro screening of crude extracts and pure metabolites obtained from marine invertebrates for the treatment of breast cancer. Cancer Chemother Pharmacol 30: 401
17. Talpir R, Benayahu Y, Kashman Y, et al (1994) Hemiasterlin and geodiamolide TA-two new cytotoxic peptides from the marine sponge Hemiastrella minor. (Kirkpatrick) Tetrahedron Lett 35: 2589
18. Teicher BA, Holden SA, Ara G et al (1993) Cyclooxygenase inhibitors: in vitro and in vivo effects on antitumor alkylating acents in the EMT-6 murine mammary carcinoma. Int J Oncol 2: 145
19. Teicher BA, Korbut TT, Menon K, et al (1994) Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies. Cancer Chemother Pharmacol 33: 515
20. Teicher B, Bump E, Palayoor S, et al (1996) Signal transduction inhibitors as modifiers of radiation therapy in human prostate carcinoma xenografts. Radiat Oncol Investig 4: 221
21. Teicher BA, Kakeji Y, Ara G et al (1997) Prostate Carcinoma response to cytotoxic therapy: in vivo resistance. In Vivo 11: 453
22. Zabriskie TM, Klocke JA, Ireland CM, et al (1986) Jaspamide, a modified peptide from a Jaspis sponge, with insecticidal and antifungal activity. J Am Chem Soc 108: 3123